Gábor A Dunay1,2, Ilona Tóth3, Johanna M Eberhard1,3, Olaf Degen4,2, Eva Tolosa5, Jan van Lunzen1,4,2, Joachim Hauber1,2, Julian Schulze Zur Wiesch1,3,2. 1. Heinrich Pette Institute - Leibniz Institute for Experimental Virology, Hamburg, Germany. 2. DZIF Partner Site (German Center for Infection Research), Hamburg, Germany. 3. 1. Department of Medicine, University Medical Center Hamburg-Eppendorf, Germany. 4. Health Care Center, University Medical Center Hamburg-Eppendorf, Germany. 5. Department of Immunology, University Medical Center Hamburg-Eppendorf, Germany.
Abstract
INTRODUCTION: Th17 cells can either be identified by co-staining of surface markers or by intracellular cytokine staining (ICS) for IL-17 production. Discrepancies regarding the published frequencies of Th17 cells in peripheral blood mononuclear cells (PBMC) of HIV patients may partly be due to the different methodologies used. METHODS: Cryopreserved PBMC from healthy controls and HIV-infected subjects, including treated (cART) and viremic patients, were split and analyzed side-by-side by flow cytometry for expression of surface markers CCR6, CXCR3, CCR4, and CD161, or for intracellular expression of IL-17A and IFNγ after stimulation. RESULTS: The characterization of Th17 cells as CXCR3 - CCR6 + CCR4 + CD161+ yielded considerably higher frequencies than the corresponding frequencies obtained by characterization via cytokines (IL-17 + IFNγ-), regardless of the HIV status. However, the overall frequencies delivered by the two methods significantly correlated. The relative frequency of Th17 cells within the CD4+ T cell compartment was preserved in HIV infection but there was a significant decrease in the absolute Th17 number, which was restored after initiation of cART, paralleling CD4+ T cell recovery. Absolute Th17 numbers inversely correlated with HIV viral load. CONCLUSION: The definition of Th17 cells by surface markers might overestimate their frequency in comparison to functional assessment of IL-17 production by ICS, regardless of the HIV infection status. However, both methods yield proportionate results with reduced absolute numbers of Th17 cells in untreated HIV disease, reflecting the depletion of total CD4+ T cells in viremic HIV patients, and restoration with cART.
INTRODUCTION: Th17 cells can either be identified by co-staining of surface markers or by intracellular cytokine staining (ICS) for IL-17 production. Discrepancies regarding the published frequencies of Th17 cells in peripheral blood mononuclear cells (PBMC) of HIVpatients may partly be due to the different methodologies used. METHODS: Cryopreserved PBMC from healthy controls and HIV-infected subjects, including treated (cART) and viremic patients, were split and analyzed side-by-side by flow cytometry for expression of surface markers CCR6, CXCR3, CCR4, and CD161, or for intracellular expression of IL-17A and IFNγ after stimulation. RESULTS: The characterization of Th17 cells as CXCR3 - CCR6 + CCR4 + CD161+ yielded considerably higher frequencies than the corresponding frequencies obtained by characterization via cytokines (IL-17 + IFNγ-), regardless of the HIV status. However, the overall frequencies delivered by the two methods significantly correlated. The relative frequency of Th17 cells within the CD4+ T cell compartment was preserved in HIV infection but there was a significant decrease in the absolute Th17 number, which was restored after initiation of cART, paralleling CD4+ T cell recovery. Absolute Th17 numbers inversely correlated with HIV viral load. CONCLUSION: The definition of Th17 cells by surface markers might overestimate their frequency in comparison to functional assessment of IL-17 production by ICS, regardless of the HIV infection status. However, both methods yield proportionate results with reduced absolute numbers of Th17 cells in untreated HIV disease, reflecting the depletion of total CD4+ T cells in viremic HIVpatients, and restoration with cART.
Authors: David San Segundo; Luis H Galván-Espinoza; Emilio Rodrigo; Juan Irure; Juan C Ruiz; Gema Fernández-Fresnedo; Laura Riesco; Jairo Bada; Lara Belmar; Marcos Lopez-Hoyos Journal: Transplant Direct Date: 2019-02-08
Authors: Tom Diedrich; Silke Kummer; Antonio Galante; Andreas Drolz; Veronika Schlicker; Ansgar W Lohse; Johannes Kluwe; Johanna Maria Eberhard; Julian Schulze Zur Wiesch Journal: PLoS One Date: 2020-03-13 Impact factor: 3.240
Authors: Jana Libera; Melanie Wittner; Marcus Kantowski; Robin Woost; Johanna M Eberhard; Jocelyn de Heer; Dominik Reher; Samuel Huber; Friedrich Haag; Julian Schulze Zur Wiesch Journal: Front Immunol Date: 2020-09-24 Impact factor: 7.561
Authors: Marissa Herrmann; Sophia Schulte; Nils H Wildner; Melanie Wittner; Thomas Theo Brehm; Michael Ramharter; Robin Woost; Ansgar W Lohse; Thomas Jacobs; Julian Schulze Zur Wiesch Journal: Front Immunol Date: 2020-08-26 Impact factor: 7.561